Joel Greenblatt's BEAM Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 10,720 shares of Beam Therapeutics Inc. (BEAM) worth $367,910, representing 0.00% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 3 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in BEAM for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 10,720 shares. Largest reduction occurred in Q2 2024, reducing 14,932 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Beam Therapeutics (BEAM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Beam Therapeutics (BEAM) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +10,720 | New Buy | 10,720 | $34.32 |
| Q2 2024 | -14,932 | Sold Out | 0 | $0.00 |
| Q1 2024 | +14,932 | New Buy | 14,932 | $33.04 |
Joel Greenblatt's Beam Therapeutics Investment FAQs
Joel Greenblatt first purchased Beam Therapeutics Inc. (BEAM) in Q1 2024, acquiring 14,932 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Beam Therapeutics Inc. (BEAM) for 3 quarters since Q1 2024.
Joel Greenblatt's largest addition to Beam Therapeutics Inc. (BEAM) was in Q1 2024, adding 14,932 shares worth $493,353.
According to the latest 13F filing for Q2 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 10,720 shares of Beam Therapeutics Inc. (BEAM), valued at approximately $367,910.
As of the Q2 2026 filing, Beam Therapeutics Inc. (BEAM) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Beam Therapeutics Inc. (BEAM) was 14,932 shares, as reported at the end of Q1 2024.